Scythian Biosciences Corp. Forms Professional Athlete Advisory Committee
27 sept. 2017 17h00 HE
|
Scythian Biosciences Corp.
TORONTO, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company") (TSX-V:SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose...
Scythian Biosciences Corp. Appoints Chief Scientific Officer
05 sept. 2017 06h00 HE
|
Scythian Biosciences Corp.
TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company") (TSX-V:SCYB) is pleased to announce that Maghsoud Dariani has become the Chief Scientific Officer of the...
Scythian Biosciences Corp. Applies for Listing of Common Stock on NASDAQ
29 août 2017 17h59 HE
|
Scythian Biosciences Corp.
TORONTO, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (TSXV:SCYB) (the "Company") is pleased to announce that it has submitted an initial listing application to list its common...
Scythian Biosciences Corp. Retains The Weinberg Group To Provide FDA Consulting Services
28 août 2017 11h22 HE
|
Scythian Biosciences Corp.
TORONTO, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company”) (TSXV:SCYB) is pleased to announce that it has entered into a consulting arrangement with The Weinberg Group and...
Scythian Biosciences Corp. Retains Hybrid Financial Ltd. for Investor Relations Activities
17 août 2017 09h24 HE
|
Scythian Biosciences Corp.
TORONTO, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company”) (TSXV:SCYB) announces that it has retained the services of Hybrid Financial Ltd. (”Hybrid Financial”) for...